Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

67.24 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 108
Open 67.24
Bid (Size) 67.07 (1)
Ask (Size) 67.29 (1)
Prev. Close 67.24
Today's Range 67.24 - 67.24
52wk Range 56.56 - 73.34
Shares Outstanding 1,253,809,440
Dividend Yield 4.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Gilead Presents Long-Term Switch Data Reinforcing Biktarvy® as a Treatment Option for a Broad Range of People Living With HIV
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the company’s upcoming contributions to the 18th European AIDS Conference (EACS 2021), taking place virtually and onsite in London from October... 
From Business Wire News Releases
Gilead Sciences Announces Veklury® Donations to Help Address the Ongoing COVID-19 Crisis in Indonesia and Armenia
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company will donate 100,000 vials of Veklury® (remdesivir) to help address the recent surge of COVID-19 cases in Indonesia and 3,000 vials... 
From Business Wire News Releases

Performance

YTD
+11.86%
+11.86%
1 Month
-5.55%
-5.55%
3 Month
-2.20%
-2.20%
6 Month
+2.25%
+2.25%
1 Year
+12.14%
+12.14%

More News

Read More
U.S. Food and Drug Administration Approves Expanded Indication of Gilead’s Biktarvy® for Treatment of HIV-1 in Pediatric Populations
From Business Wire News Releases
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer
From Business Wire News Releases
Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021
From Business Wire News Releases
Notable ETF Outflow Detected - IBB, GILD, REGN, ILMN
Tags ETFs
From ETF Channel
Interesting GILD Put And Call Options For December 3rd
Tags Stocks
From Market News Video
Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?
Tags Market News BMY AGEN
From Motley Fool
2 High-Yielding Stocks You Can Buy and Hold for Years
Tags Market News CPB GILD
From Motley Fool
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
Tags GILD Market News MRK
From Motley Fool
3 Under-the-Radar COVID Stocks
Tags GILD SHOP NARI
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.